Abstract
Purpose
Obesity is well known to be linked to higher morbidity and mortality. Elevated plasma levels of free dehydroepiandrosterone (DHEA) are associated with reduced obesity and more limited accumulation of abdominal body fat. In contrast, the relationship between the DHEA sulfate ester (DHEAS) and adiposity is inconsistent and contradictory.
Methods
The aim of this study was to compare DHEAS levels in obese Turkish individuals, 37 men and 246 women. A variety of fatness, hormone, and blood parameters were measured.
Results
Statistically significant differences were found between male and female individuals with respect to weight, waist circumference, fat %, insulin, and DHEAS levels.
Conclusions
We found that in the Turkish population, while a correlation between obesity parameters and DHEAS levels exists in both female and male individuals, DHEAS levels are significantly higher in obese male individuals than in obese female individuals.
References
Abbasi A, Duthie EH, Sheldahl L et al (1998) Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc 46(3):263–273
Barrett-Connor E, Ferrara A (1996) Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 81(1):59–64
Baulieu EE (2002) Androgens and aging men. Mol Cell Endocrinol 198:41–49
Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763
Berr C, Lafont S, Debuire B et al (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93(23):13410–13415
Butcher SK, Lord JM (2004) Stress responses and innate immunity: aging as a contributory factor. Aging Cell 3(4):151–160
Celec P, Starka L (2003) Dehydroepiandrosterone—is the fountain of youth drying out? Physiol Res 52(4):397–407
Chen MJ, Chen CD, Yang JH, Chen CL, Ho HN, Yang WS, Yang YS (2011) High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Rep 26(1):227–234
Feldman HA, Johannes CB, Araujo AB et al (2001) Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts male aging study. Am J Epidemiol 153(1):79–89
Friess E, Schiffelholz T, Steckler T, Steiger A (2000) Dehydroepiandrosterone—a neurosteroid. Eur J Clin Invest 30(3):46–50
Glei DA, Goldman N, Weinstein M et al (2004) Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex? Exp Gerontol 39(3):321–331
Himes CL (2000) Obesity, disease, and functional limitation in later life. Demography 37(1):73–82
Hsieh CCSL, Lipworth L, Lagiou P, Mantzoros CS, Trichopoulos D (1998) Predictors of sex hormone levels among the elderly: a study in Greece. J Clin Epidemiol 51(10):837–841
Kawai S, Yahata N, Nishida S, Mizushima Y (1995) Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation. Anticancer Res 15(2):427–431
Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74:761–811
Labrie F, Belanger A, Luu-The V, Labrie C, Simard J et al (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 63:322–328
Labrie F, Luu-The V, Bélanger A, Lin S-X, Simard J, Pelletier G, Labrie C (2005) Is dehydroepiandrosterone a hormone? J Endocrinol 187:169–196
Lee JS, Kritchevsky SB, Tylavsky F et al (2005) Weight change, weight change intention, and the incidence of mobility limitation in well-functioning community-dwelling older adults. J Gerontol A Biol Sci Med Sci 60(8):1007–1012
Mo Q, Lu SF, Simon NG (2006) Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. J Steroid Biochem Mol Biol 99(1):50–58
Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988) Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66:57–61
Phillips AC, Carroll D, Gale CR, Lord JM, Arlt W, Batty GD (2010) Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam Experience Study. Eur J Endocrinol 162(5):919–923
Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS et al (2006) Metaanalysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8:538–554
Savastano S, Belfiore A, Guida B, Angrisani L, Orio F, Cascella T, Milone F, Micanti F, Saldalamacchia G, Lombardi G, Colao A (2005) Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. J Endocrinol Invest 28(6):509–515
Schulman RA, Dean C (2007) DHEA (Dehydroepiandrosterone) is a common hormone produced in the adrenal glands, the gonads, and the brain. Solve it with supplements. Rodale, Inc, New York City, p 100
Tchernof A, Labrie F (2004) Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 151:1–14
Tchernof A, Poehlman ET (1998) Effects of the menopause transition on body fatness and body fat distribution. Obes Res 6:246–254
Thijssen JHH, Nieuwenhuyse H (1999) DHEA: a comprehensive review. Parthenon, Pearl River
Tsai MJ, O’Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451–486
Voelzke H, Aumann N, Krebs A, Nauck M, Steveling A, Lerch M, Rosskopf D, Wallaschofski H (2010) Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl 33(1):45–53
Voznesensky M, Walsh S, Dauser D, Brindisi J, Kenny AM (2009) The association between dehydroepiandrosterone and frailty in older men and women. Age Ageing 38:401–406
Walston J, McBurnie MA, Newman A et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333–2341
Webb SJ, Geoghegan TE, Prough RA, Michael Miller KK (2006) The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38(1–2):89–116
William F, Ganong MD (2005) Review of medical physiology, 22nd edn. McGraw Hill, USA, p 362
Conflict of interest
There is no conflict interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Topsakal, S., Akin, F., Yerlikaya, E. et al. Dehydroepiandrosterone sulfate levels in Turkish obese patients. Eat Weight Disord 19, 261–265 (2014). https://doi.org/10.1007/s40519-014-0120-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40519-014-0120-9